Another study showed that in pancreatic cancer, IGHG1 can reduce the cytotoxic activity of NK cells by inhibiting antibody-dependent cellular cytotoxicity function and ultimately producing the effect of contributing to cancer cell proliferation and immune escape [48]. Here, IGHG1 is linked to pancreatic neoplasm.